Sponsors (10)
The bill increases federal attention, outreach, and coordinated research to address endometrial cancer and racial disparities—potentially improving early detection and equity—but limited dedicated funding and implementation risks (stigmatization, misinterpretation, and logistical hurdles for trials) could substantially reduce its effectiveness.
Women — especially postmenopausal women and African‑American/minority women — will receive increased, targeted public information about endometrial cancer risk and treatments, improving awareness and prompting earlier care-seeking and detection.
NIH-supported research and coordination on endometrial cancer will increase (through alignment of institutes and focused programs), potentially accelerating better diagnostics, treatments, and understanding of disparities.
Clinical research will be more inclusive: NIH-required proportional enrollment of African‑American women aims to improve equity and make study results more generalizable to populations with higher incidence.
The NIH appropriation is small ($1 million per year) and is likely insufficient to fund large-scale research, trial recruitment, or system-level interventions, limiting the bill’s potential impact.
Targeted messaging that emphasizes higher incidence or mortality among African‑American and other minority women risks stigmatizing those communities unless paired with culturally sensitive materials and concrete support programs.
Requiring proportional representation of African‑American women in NIH clinical trials could complicate or slow trial enrollment and logistics if adequate recruitment resources and infrastructure are not provided.
Based on analysis of 3 sections of legislative text.
Directs NIH and CDC to expand endometrial cancer research and public education, require trial inclusion for African‑American women, and authorizes limited funding for FY2026–2028.
Official title: To amend the Public Health Service Act to expand research and education with respect to endometrial cancer, and for other purposes.
Introduced September 9, 2025 by David Scott · Last progress September 9, 2025
Directs the NIH and CDC to step up research, coordination, and public education on endometrial cancer and to address racial disparities in outcomes. The bill requires NIH to expand and coordinate endometrial cancer research, improve communication about diagnostic disparities (including via CDC outreach), and increase African‑American women’s representation in NIH‑funded clinical trials; it authorizes $1 million per year for FY2026–2028 for NIH and provides unspecified funding authority for CDC activities to develop targeted informational materials, including materials aimed at African‑American women.